期刊
ANNALS OF ONCOLOGY
卷 23, 期 -, 页码 92-97出版社
OXFORD UNIV PRESS
DOI: 10.1093/annonc/mds310
关键词
immunotoxins; lymphomas; monoclonal antibodies; small molecules
类别
Despite improvements in the diagnosis and management of lymphomas, many patients remain incurable with available treatments. Advances in preclinical research and a better understanding of the molecular biology of lymphomas have allowed the development of a high number of therapeutic agents with innovative mechanisms of action. Many of these new agents have shown activity in patients not responding to standard treatments and there is optimism that their incorporation into the standard of care can result in improved treatment outcomes. Here we review new monoclonal antibodies and small molecules that have recently entered clinical evaluation for patients with lymphomas.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据